| OPKO HEALTH INC. DL-,01 |
| USA |
| Gesundheit |
| US68375N1037 / A0MUUJ |
| XCY (Frankfurt) / OPK (NASDAQ) |
| FRA:XCY, ETR:XCY, XCY:GR, NASDAQ:OPK |
| - |
| https://www.opko.com/ |
|
OpKO Health Inc. is a multinational biopharmaceutical and diagnostics company operating through two primary segments: Pharmaceuticals and Diagnostics. In the Pharmaceuticals segment, it develops and commercializes therapies such as Rayaldee, FDA-appr..
>Volltext.. |
| 783.11 Mio. EUR |
| 830.88 Mio. EUR |
| 510.75 Mio. EUR |
| -98.87 Mio. EUR |
| -187.13 Mio. EUR |
| -0.24 EUR |
| 348.86 Mio. EUR |
| 300.48 Mio. EUR |
| -143.52 Mio. EUR |
| 2.3 |
| -21.07% |
| -410.83% |
| - |
| - |
| - |
| - |
| OPKO HEALTH |
| 24.07.26 |
|